{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T19:09:50Z","timestamp":1794942590626,"version":"4.9.1"},"reference-count":88,"publisher":"The Endocrine Society","issue":"8","license":[{"start":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T00:00:00Z","timestamp":1678752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Center","doi-asserted-by":"publisher","award":["2016\/23\/D\/NZ3\/01660"],"award-info":[{"award-number":["2016\/23\/D\/NZ3\/01660"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005297","name":"Medical University of Bialystok","doi-asserted-by":"publisher","award":["SUB\/1\/DN\/22\/005\/1118"],"award-info":[{"award-number":["SUB\/1\/DN\/22\/005\/1118"]}],"id":[{"id":"10.13039\/501100005297","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The worldwide increase in the prevalence of diabetes mellitus has raised the demand for new therapeutic strategies targeting diabetic symptoms and its chronic complications. Among different treatment options for diabetes, adipose-derived mesenchymal stem cells (ADMSCs) therapy attract the most attention. The therapeutic effects of ADMSCs are based primarily on their paracrine release of immunomodulatory, anti-inflammatory, and trophic factors. Animal models of diabetes as well as human clinical trials have shown that ADMSCs can effectively facilitate endogenous \u03b2 cell regeneration, preserve residual \u03b2 cell mass, reduce islet graft rejection, regulate the immune system, and ultimately improve insulin sensitivity or ameliorate insulin resistance in peripheral tissues. Nevertheless, transplantation of mesenchymal stem cells is associated with certain risks; therefore recently much attention has been devoted to ADMSCs derivatives, such as exosomes or conditioned media, as therapeutic agents for the treatment of diabetes. Compared to ADMSCs, cell-free therapy has even better therapeutic potential. This narrative review summarizes recent outcomes and molecular mechanisms of ADMSCs action in the treatment for both type 1 DM and type 2 DM, as well as shows their feasibility, benefits, and current limitations.<\/jats:p>","DOI":"10.1210\/clinem\/dgad142","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T09:57:48Z","timestamp":1678787868000},"page":"1889-1897","source":"Crossref","is-referenced-by-count":85,"title":["Adipose-derived Mesenchymal Stem Cells Therapy as a new Treatment Option for Diabetes Mellitus"],"prefix":"10.1210","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4936-3120","authenticated-orcid":false,"given":"Agnieszka","family":"Mik\u0142osz","sequence":"first","affiliation":[{"name":"Department of Physiology, Medical University of Bialystok , 15-222 Bialystok , Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Chabowski","sequence":"additional","affiliation":[{"name":"Department of Physiology, Medical University of Bialystok , 15-222 Bialystok , Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2023,3,14]]},"reference":[{"key":"2023071417174939000_dgad142-B1","author":"International Diabetes Federation"},{"issue":"7","key":"2023071417174939000_dgad142-B2","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/ejcn.2017.45","article-title":"The bioenergetics of inflammation: insights into obesity and type 2 diabetes","volume":"71","author":"Keane","year":"2017","journal-title":"Eur J Clin Nutr"},{"issue":"1","key":"2023071417174939000_dgad142-B3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1001\/jama.2018.7993","article-title":"Association of initiation of basal insulin analogs vs neutral protamine Hagedorn insulin with hypoglycemia-related emergency department visits or hospital admissions and with glycemic control in patients with type 2 diabetes","volume":"320","author":"Lipska","year":"2018","journal-title":"J Am Med Assoc"},{"key":"2023071417174939000_dgad142-B4","doi-asserted-by":"crossref","first-page":"690623","DOI":"10.3389\/fimmu.2021.690623","article-title":"From mesenchymal stromal\/stem cells to insulin-producing cells: immunological considerations","volume":"12","author":"Refaie","year":"2021","journal-title":"Front Immunol"},{"key":"2023071417174939000_dgad142-B5","doi-asserted-by":"crossref","first-page":"78064","DOI":"10.1155\/2018\/7806435","article-title":"Addressing stem cell therapeutic approaches in pathobiology of diabetes and its complications","volume":"2018","author":"Peng","year":"2018","journal-title":"J. Diabetes Res"},{"issue":"12","key":"2023071417174939000_dgad142-B6","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.2337\/diacare.26.12.3288","article-title":"Benefits and risks of solitary islet transplantation for type 1 diabetes","volume":"26","author":"Hirshberg","year":"2003","journal-title":"Diabetes Care"},{"issue":"4","key":"2023071417174939000_dgad142-B7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/MOT.0000000000000891","article-title":"Update on islet cell transplantation","volume":"26","author":"Verhoeff","year":"2021","journal-title":"Curr Opin Organ Transplant"},{"key":"2023071417174939000_dgad142-B8","doi-asserted-by":"crossref","first-page":"451035","DOI":"10.1155\/2014\/451035","article-title":"Inflammatory response in islet transplantation","volume":"2014","author":"Kanak","year":"2014","journal-title":"Int J Endocrinol"},{"issue":"11","key":"2023071417174939000_dgad142-B9","doi-asserted-by":"crossref","first-page":"e0206449","DOI":"10.1371\/journal.pone.0206449","article-title":"Improved islet recovery and efficacy through co-culture and co-transplantation of islets with human adipose-derived mesenchymal stem cells","volume":"13","author":"Gamble","year":"2018","journal-title":"PLoS One"},{"issue":"25","key":"2023071417174939000_dgad142-B10","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1056\/NEJMoa043980","article-title":"Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes","volume":"352","author":"Keymeulen","year":"2005","journal-title":"N Engl J Med"},{"issue":"9790","key":"2023071417174939000_dgad142-B11","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0140-6736(11)60931-8","article-title":"Teplizumab for treatment of type 1 diabetes (Prot\u00e9g\u00e9 study): 1-year results from a randomised, placebo-controlled trial","volume":"378","author":"Sherry","year":"2011","journal-title":"Lancet"},{"issue":"7","key":"2023071417174939000_dgad142-B12","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3390\/biom11070918","article-title":"Adipose tissue: understanding the heterogeneity of stem cells for regenerative medicine","volume":"11","author":"Ong","year":"2021","journal-title":"Biomolecules"},{"issue":"3","key":"2023071417174939000_dgad142-B13","first-page":"381","article-title":"Osteogenesis in transplants of bone marrow cells","volume":"16","author":"Friedenstein","year":"1966","journal-title":"J Embryol Exp Morphol"},{"issue":"4","key":"2023071417174939000_dgad142-B14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"issue":"9","key":"2023071417174939000_dgad142-B15","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/stem.2847","article-title":"Concise review: using fat to fight disease: a systematic review of nonhomologous adipose-derived stromal\/stem cell therapies","volume":"36","author":"Bateman","year":"2018","journal-title":"Stem Cells"},{"issue":"3","key":"2023071417174939000_dgad142-B16","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.3892\/mmr.2015.3847","article-title":"Intrahepatic transplantation of adipose-derived stem cells attenuates the progression of non-alcoholic fatty liver disease in rats","volume":"12","author":"Pan","year":"2015","journal-title":"Mol Med Rep"},{"issue":"6","key":"2023071417174939000_dgad142-B17","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/stem.430","article-title":"A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke","volume":"28","author":"Lee","year":"2010","journal-title":"Stem Cells"},{"issue":"12","key":"2023071417174939000_dgad142-B18","doi-asserted-by":"crossref","first-page":"e113936","DOI":"10.1371\/journal.pone.0113936","article-title":"Randomized placebo-controlled phase II trial of autologous mesenchymal stem cells in multiple sclerosis","volume":"9","author":"Llufriu","year":"2014","journal-title":"PLoS One"},{"issue":"10051","key":"2023071417174939000_dgad142-B19","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0140-6736(16)31203-X","article-title":"Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial","volume":"388","author":"Pan\u00e9s","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"2023071417174939000_dgad142-B20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/kisup.2011.24","article-title":"Protective actions of administered mesenchymal stem cells in acute kidney injury: relevance to clinical trials","volume":"1","author":"Westenfelder","year":"2011","journal-title":"Kidney Int Suppl"},{"issue":"10","key":"2023071417174939000_dgad142-B21","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1097\/MEG.0b013e32832a1f6c","article-title":"Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial","volume":"21","author":"Kharaziha","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"5","key":"2023071417174939000_dgad142-B22","doi-asserted-by":"crossref","first-page":"e13413","DOI":"10.1111\/obr.13413","article-title":"Using adipose-derived mesenchymal stem cells to fight the metabolic complications of obesity: where do we stand?","volume":"23","author":"Mik\u0142osz","year":"2022","journal-title":"Obes Rev"},{"issue":"46","key":"2023071417174939000_dgad142-B23","doi-asserted-by":"crossref","first-page":"17438","DOI":"10.1073\/pnas.0608249103","article-title":"Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD\/scid mice","volume":"103","author":"Lee","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2023071417174939000_dgad142-B24","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/stem.1132","article-title":"The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore Th1\/Th2 balance and to modify the pancreatic microenvironment","volume":"30","author":"Ezquer","year":"2012","journal-title":"Stem Cells"},{"issue":"22","key":"2023071417174939000_dgad142-B25","first-page":"3622","article-title":"Autologous bone marrow stem cell transplantation for the treatment of type 2 diabetes mellitus","volume":"124","author":"Wang","year":"2011","journal-title":"Chin Med J (Engl)"},{"issue":"5","key":"2023071417174939000_dgad142-B26","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.3892\/etm.2015.2339","article-title":"Therapeutic efficacy of umbilical cord-derived mesenchymal stem cells in patients with type 2 diabetes","volume":"9","author":"Guan","year":"2015","journal-title":"Exp Ther Med"},{"issue":"7","key":"2023071417174939000_dgad142-B27","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/cbf.3056","article-title":"Characterization of human adipose tissue-derived stromal cells isolated from diabetic patient's distal limbs with critical ischemia","volume":"32","author":"Ko\u010d\u00ed","year":"2014","journal-title":"Cell Biochem Funct"},{"issue":"12","key":"2023071417174939000_dgad142-B28","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.2337\/db13-0896","article-title":"Adipose mesenchymal stromal cells isolated from type 2 diabetic patients display reduced fibrinolytic activity","volume":"62","author":"Acosta","year":"2013","journal-title":"Diabetes"},{"issue":"11","key":"2023071417174939000_dgad142-B29","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1016\/j.ymthe.2018.08.011","article-title":"PDGF restores the defective phenotype of adipose-derived mesenchymal stromal cells from diabetic patients","volume":"26","author":"Capilla-Gonz\u00e1lez","year":"2018","journal-title":"Mol Ther"},{"issue":"5","key":"2023071417174939000_dgad142-B30","doi-asserted-by":"crossref","first-page":"328","DOI":"10.5966\/sctm.2012-0116","article-title":"Stem cell therapy to cure type 1 diabetes: from hype to hope","volume":"2","author":"Chhabra","year":"2013","journal-title":"Stem Cells Transl Med"},{"issue":"4","key":"2023071417174939000_dgad142-B31","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2217\/17460751.3.4.531","article-title":"Immunomodulatory effect of mesenchymal stromal cells: possible mechanisms","volume":"3","author":"Nasef","year":"2008","journal-title":"Regen Med"},{"key":"2023071417174939000_dgad142-B32","doi-asserted-by":"crossref","first-page":"1653254","DOI":"10.1155\/2017\/1653254","article-title":"Trophic activity and phenotype of adipose tissue-derived mesenchymal stem cells as a background of their regenerative potential","volume":"2017:","author":"Kocan","year":"2017","journal-title":"Stem Cells Int"},{"issue":"4","key":"2023071417174939000_dgad142-B33","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.bbrc.2006.01.072","article-title":"Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells","volume":"341","author":"Timper","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"2023071417174939000_dgad142-B34","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1002\/stem.127","article-title":"Insulin-secreting cells from human eyelid-derived stem cells alleviate type I diabetes in immunocompetent mice","volume":"27","author":"Kang","year":"2009","journal-title":"Stem Cells"},{"issue":"2","key":"2023071417174939000_dgad142-B35","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10616-013-9573-3","article-title":"In-vitro generation of human adipose tissue derived insulin secreting cells: up-regulation of Pax-6, Ipf-1 and Isl-1","volume":"66","author":"Dave","year":"2014","journal-title":"Cytotechnology"},{"issue":"6","key":"2023071417174939000_dgad142-B36","doi-asserted-by":"crossref","first-page":"e20615","DOI":"10.1371\/journal.pone.0020615","article-title":"Islet-like cell aggregates generated from human adipose tissue derived stem cells ameliorate experimental diabetes in mice","volume":"6","author":"Chandra","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"2023071417174939000_dgad142-B37","first-page":"310","article-title":"In vivo differentiation of mesenchymal stem cells into insulin producing cells on electrospun poly-L-lactide acid scaffolds coated with Matricaria chamomilla L. Oil","volume":"18","author":"Fazili","year":"2016","journal-title":"Cell J"},{"issue":"8","key":"2023071417174939000_dgad142-B38","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jcyt.2017.05.003","article-title":"Sonic hedgehog pathway suppression and reactivation accelerates differentiation of rat adipose-derived mesenchymal stromal cells toward insulin-producing cells","volume":"19","author":"Dayer","year":"2017","journal-title":"Cytotherapy"},{"issue":"2","key":"2023071417174939000_dgad142-B39","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10047-009-0455-6","article-title":"Transdifferentiation of human adipose tissue-derived stromal cells into insulin-producing clusters","volume":"12","author":"Okura","year":"2009","journal-title":"J Artif Organs"},{"issue":"6","key":"2023071417174939000_dgad142-B40","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3727\/096368912X657215","article-title":"Differentiation of human adipose tissue-derived stem cells into aggregates of insulin-producing cells through the overexpression of pancreatic and duodenal homeobox gene-1","volume":"22","author":"Lee","year":"2013","journal-title":"Cell Transplant"},{"issue":"4","key":"2023071417174939000_dgad142-B41","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3892\/ijmm.2017.2914","article-title":"Transplantation of betatrophin-expressing adipose-derived mesenchymal stem cells induces \u03b2-cell proliferation in diabetic mice","volume":"39","author":"Sun","year":"2017","journal-title":"Int J Mol Med"},{"issue":"2","key":"2023071417174939000_dgad142-B42","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2337\/db14-0656","article-title":"Preserved \u03b2-cell function in type 1 diabetes by mesenchymal stromal cells","volume":"64","author":"Carlsson","year":"2015","journal-title":"Diabetes"},{"issue":"3","key":"2023071417174939000_dgad142-B43","doi-asserted-by":"crossref","first-page":"98","DOI":"10.7603\/s40730-014-0016-3","article-title":"Preliminary evaluation of intravenous infusion and intrapancreatic injection of human umbilical cord blood-derived mesenchymal stem cells for the treatment of diabetic mice","volume":"1","author":"Phan","year":"2014","journal-title":"Biomed Res Ther"},{"issue":"1","key":"2023071417174939000_dgad142-B44","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13287-015-0017-1","article-title":"Therapeutic efficacy and biodistribution of allogeneic mesenchymal stem cells delivered by intrasplenic and intrapancreatic routes in streptozotocin-induced diabetic mice","volume":"6","author":"Yaochite","year":"2015","journal-title":"Stem Cell Res Ther"},{"issue":"10","key":"2023071417174939000_dgad142-B45","doi-asserted-by":"crossref","first-page":"e0186637","DOI":"10.1371\/journal.pone.0186637","article-title":"Intrapancreatic injection of human bone marrow-derived mesenchymal stem\/stromal cells alleviates hyperglycemia and modulates the macrophage state in streptozotocin-induced type 1 diabetic mice","volume":"12","author":"Murai","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"2023071417174939000_dgad142-B46","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13287-021-02173-4","article-title":"Intrapancreatic MSC transplantation facilitates pancreatic islet regeneration","volume":"12","author":"Khatri","year":"2021","journal-title":"Stem Cell Res Ther"},{"issue":"10","key":"2023071417174939000_dgad142-B47","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.2337\/db11-0844","article-title":"Immune regulatory properties of allogeneic adipose-derived mesenchymal stem cells in the treatment of experimental autoimmune diabetes","volume":"61","author":"Bassi","year":"2012","journal-title":"Diabetes"},{"issue":"11","key":"2023071417174939000_dgad142-B48","doi-asserted-by":"crossref","first-page":"9433","DOI":"10.1002\/jcb.27260","article-title":"Immunomodulatory effects of mesenchymal stem cell\u2013derived exosomes on experimental type-1 autoimmune diabetes","volume":"119","author":"Nojehdehi","year":"2018","journal-title":"J Cell Biochem"},{"issue":"1","key":"2023071417174939000_dgad142-B49","first-page":"47","article-title":"Mesenchymal stem cell conditioned medium ameliorates diabetic serum-induced insulin resistance in 3T3-L1 cells","volume":"7","author":"Sanap","year":"2021","journal-title":"Chronic Dis Transl Med"},{"issue":"1","key":"2023071417174939000_dgad142-B50","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13287-019-1177-1","article-title":"Exosome secreted from adipose-derived stem cells attenuates diabetic nephropathy by promoting autophagy flux and inhibiting apoptosis in podocyte","volume":"10","author":"Jin","year":"2019","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"2023071417174939000_dgad142-B51","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12195-021-00699-4","article-title":"Exosomes from adipose tissues derived mesenchymal stem cells overexpressing microRNA-146a alleviate diabetic osteoporosis in rats","volume":"15","author":"Zhang","year":"2022","journal-title":"Cell Mol Bioeng"},{"issue":"1849454418807827","key":"2023071417174939000_dgad142-B52","article-title":"Adipose mesenchymal stem cells\u2013derived exosomes attenuate retina degeneration of streptozotocin-induced diabetes in rabbits","volume":"7","author":"Safwat","year":"2018","journal-title":"J Circ Biomarkers"},{"issue":"23","key":"2023071417174939000_dgad142-B53","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1042\/CS20171251","article-title":"Mesenchymal stromal cells improve human islet function through released products and extracellular matrix","volume":"131","author":"Arzouni","year":"2017","journal-title":"Clin Sci"},{"issue":"Suppl 2","key":"2023071417174939000_dgad142-B54","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.2337\/diabetes.54.suppl_2.S25","article-title":"Natural history of type 1 diabetes","volume":"54","author":"Achenbach","year":"2005","journal-title":"Diabetes"},{"issue":"12","key":"2023071417174939000_dgad142-B55","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1097\/TP.0b013e3181ffba31","article-title":"Combined transplantation of pancreatic islets and adipose tissue-derived stem cells enhances the survival and insulin function of islet grafts in diabetic mice","volume":"90","author":"Ohmura","year":"2010","journal-title":"Transplantation"},{"issue":"9","key":"2023071417174939000_dgad142-B56","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jcyt.2018.06.001","article-title":"Reduction of marginal mass required for successful islet transplantation in a diabetic rat model using adipose tissue\u2013derived mesenchymal stromal cells","volume":"20","author":"Navaei-Nigjeh","year":"2018","journal-title":"Cytotherapy"},{"issue":"5","key":"2023071417174939000_dgad142-B57","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jcyt.2013.01.005","article-title":"Adipose tissue-derived mesenchymal stromal cells efficiently differentiate into insulin-producing cells in pancreatic islet microenvironment both in vitro and in vivo","volume":"15","author":"Karaoz","year":"2013","journal-title":"Cytotherapy"},{"issue":"7","key":"2023071417174939000_dgad142-B58","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/stem.1676","article-title":"Human adipose derived stromal\/stem cells (hASCs) protect against STZ-induced hyperglycemia; analysis of hASC-derived paracrine effectors","volume":"32","author":"Kono","year":"2014","journal-title":"Stem Cells"},{"issue":"46","key":"2023071417174939000_dgad142-B59","doi-asserted-by":"crossref","first-page":"17444","DOI":"10.1073\/pnas.0608141103","article-title":"Correlation between \u03b2 cell mass and glycemic control in type 1 diabetic recipients of islet cell graft","volume":"103","author":"Keymeulen","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2023071417174939000_dgad142-B60","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/00007890-199503000-00003","article-title":"A selective decrease in the beta cell mass of human islets transplanted into diabetic nude mice","volume":"59","author":"Davalli","year":"1995","journal-title":"Transplantation"},{"issue":"1","key":"2023071417174939000_dgad142-B61","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3727\/215517914X680047","article-title":"Preculturing islets with adipose-derived mesenchymal stromal cells is an effective strategy for improving transplantation efficiency at the clinically preferred intraportal site","volume":"7","author":"Rackham","year":"2014","journal-title":"Cell Med"},{"issue":"4","key":"2023071417174939000_dgad142-B62","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jcyt.2012.11.008","article-title":"Pre-culturing islets with mesenchymal stromal cells using a direct contact configuration is beneficial for transplantation outcome in diabetic mice","volume":"15","author":"Rackham","year":"2013","journal-title":"Cytotherapy"},{"issue":"6","key":"2023071417174939000_dgad142-B63","first-page":"694","article-title":"Factors affecting graft and patient survival after live donor kidney transplantation in the UK","volume":"89","author":"Fuggle","year":"2010","journal-title":"Transplantation"},{"issue":"1","key":"2023071417174939000_dgad142-B64","doi-asserted-by":"crossref","first-page":"e84309","DOI":"10.1371\/journal.pone.0084309","article-title":"A double mechanism for the mesenchymal stem cells\u2019 positive effect on pancreatic islets","volume":"9","author":"Scuteri","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"2023071417174939000_dgad142-B65","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jss.2013.10.031","article-title":"Trophic effect of adipose tissue-derived stem cells on porcine islet cells","volume":"187","author":"Yamada","year":"2014","journal-title":"J Surg Res"},{"issue":"4","key":"2023071417174939000_dgad142-B66","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1507\/endocrj.EJ14-0584","article-title":"Effects of autologous adipose-derived stem cell infusion on type 2 diabetic rats","volume":"62","author":"Hu","year":"2015","journal-title":"Endocr J"},{"issue":"1","key":"2023071417174939000_dgad142-B67","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/s13287-019-1474-8","article-title":"Treatment with adipose tissue-derived mesenchymal stem cells exerts anti-diabetic effects, improves long-term complications, and attenuates inflammation in type 2 diabetic rats","volume":"10","author":"Yu","year":"2019","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"2023071417174939000_dgad142-B68","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.bbrc.2016.12.125","article-title":"Adipose-derived mesenchymal stem cells ameliorate hyperglycemia through regulating hepatic glucose metabolism in type 2 diabetic rats","volume":"483","author":"Xie","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"2023071417174939000_dgad142-B69","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.bbrc.2013.10.059","article-title":"Transplantation of insulin-secreting cells differentiated from human adipose tissue-derived stem cells into type 2 diabetes mice","volume":"443","author":"Nam","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"2023071417174939000_dgad142-B70","first-page":"8466","article-title":"Infusion of adipose-derived mesenchymal stem cells inhibits skeletal muscle Mitsugumin 53 elevation and thereby alleviates insulin resistance in type 2 diabetic rats","volume":"17","author":"Deng","year":"2018","journal-title":"Mol Med Rep"},{"issue":"3","key":"2023071417174939000_dgad142-B71","first-page":"1","article-title":"Hypoxia precondition promotes adipose-derived mesenchymal stem cells based repair of diabetic erectile dysfunction via augmenting angiogenesis and neuroprotection","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"2023071417174939000_dgad142-B72","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13287-021-02205-z","article-title":"Mesenchymal stem cells modified by FGF21 and GLP1 ameliorate lipid metabolism while reducing blood glucose in type 2 diabetic mice","volume":"12","author":"Xue","year":"2021","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"2023071417174939000_dgad142-B73","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1210\/jc.2009-1756","article-title":"Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function","volume":"95","author":"Nadeau","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2023071417174939000_dgad142-B74","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-002-1009-0","article-title":"The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes","volume":"46","author":"Kahn","year":"2003","journal-title":"Diabetologia"},{"issue":"1","key":"2023071417174939000_dgad142-B75","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4093\/dmj.2021.0280","article-title":"Insulin resistance: from mechanisms to therapeutic strategies","volume":"46","author":"Lee","year":"2022","journal-title":"Diabetes Metab J"},{"issue":"8","key":"2023071417174939000_dgad142-B76","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1002\/jcb.25777","article-title":"Conditioned media from adipose tissue derived mesenchymal stem cells reverse insulin resistance in cellular models","volume":"118","author":"Shree","year":"2017","journal-title":"J Cell Biochem"},{"key":"2023071417174939000_dgad142-B77","doi-asserted-by":"crossref","first-page":"8833467","DOI":"10.1155\/2021\/8833467","article-title":"Antioxidative capacity of liver- and adipose-derived mesenchymal stem cell-conditioned media and their applicability in treatment of type 2 diabetic rats","volume":"2021:","author":"Elshemy","year":"2021","journal-title":"Oxid Med Cell Longev"},{"issue":"2","key":"2023071417174939000_dgad142-B78","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.diabres.2014.04.006","article-title":"Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes","volume":"105","author":"Esser","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"2023071417174939000_dgad142-B79","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s13287-022-03114-5","article-title":"Diabetic microenvironment preconditioning of adipose tissue - derived mesenchymal stem cells enhances their anti - diabetic, anti - long - term complications, and anti - inflammatory effects in type 2 diabetic rats","volume":"13","author":"Su","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"2023071417174939000_dgad142-B80","doi-asserted-by":"crossref","first-page":"173215","DOI":"10.1016\/j.ejphar.2020.173215","article-title":"Conditioned medium of adipose derived mesenchymal stem cells reverse insulin resistance through downregulation of stress induced serine kinases","volume":"881","author":"Sanap","year":"2020","journal-title":"Eur J Pharmacol"},{"issue":"9832212","key":"2023071417174939000_dgad142-B81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/9832212","article-title":"The potential therapeutic effect of orexin-treated versus orexin-untreated adipose tissue-derived mesenchymal stem cell therapy on insulin resistance in type 2 diabetic rats","volume":"2022","author":"Boushra","year":"2022","journal-title":"J. Diabetes Res"},{"issue":"1","key":"2023071417174939000_dgad142-B82","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1186\/s13287-021-02609-x","article-title":"The safety of MSC therapy over the past 15 years: a meta-analysis","volume":"12","author":"Wang","year":"2021","journal-title":"Stem Cell Res Ther"},{"issue":"10","key":"2023071417174939000_dgad142-B83","doi-asserted-by":"crossref","first-page":"e47559","DOI":"10.1371\/journal.pone.0047559","article-title":"Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials","volume":"7","author":"Lalu","year":"2012","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"2023071417174939000_dgad142-B84","doi-asserted-by":"crossref","first-page":"1112-P","DOI":"10.2337\/db18-1112-P","article-title":"Heterologous adipose-derived mesenchymal stem cells and vitamin D supplementation in patients with recent-onset type 1 diabetes mellitus\u2014six months follow-up","volume":"67","author":"Dantas","year":"2018","journal-title":"Diabetes"},{"issue":"993","key":"2023071417174939000_dgad142-B85","first-page":"1","article-title":"Allogenic adipose tissue-derived stromal\/stem cells and vitamin D supplementation in patients with recent-onset type 1 diabetes mellitus: a 3-month follow-up pilot study","volume":"11","author":"Araujo","year":"2020","journal-title":"Front Immunol"},{"issue":"7","key":"2023071417174939000_dgad142-B86","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jcyt.2015.03.608","article-title":"Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow-derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus","volume":"17","author":"Thakkar","year":"2015","journal-title":"Cytotherapy"},{"issue":"1","key":"2023071417174939000_dgad142-B87","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10238-013-0266-1","article-title":"Novel therapy for insulin-dependent diabetes mellitus: infusion of in vitro-generated insulin-secreting cells","volume":"15","author":"Dave","year":"2015","journal-title":"Clin Exp Med"},{"issue":"582382","key":"2023071417174939000_dgad142-B88","first-page":"1","article-title":"Cotransplantation of adipose tissue-derived insulin-secreting mesenchymal stem cells and hematopoietic stem cells: a novel therapy for insulin-dependent diabetes mellitus","volume":"2010","author":"Trivedi","year":"2010","journal-title":"Stem Cells Int"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgad142\/49676419\/dgad142.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/8\/1889\/50884528\/dgad142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/8\/1889\/50884528\/dgad142.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T17:38:41Z","timestamp":1702057121000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/108\/8\/1889\/7077128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,14]]},"references-count":88,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,3,14]]},"published-print":{"date-parts":[[2023,7,14]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgad142","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,8]]},"published":{"date-parts":[[2023,3,14]]}}}